Corrigendum to “PRMT1 methylates METTL14 to modulate its oncogenic function” [Neoplasia 42 (2023) 100912]
Saved in:
| Main Authors: | Jingchao Wang, Zhen Wang, Hiroyuki Izunuka, Wenyi Wei, Jing Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558625000466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
by: Qiaoxi Xia, et al.
Published: (2025-04-01) -
Methylation of RBM39 by PRMT6 enhances resistance to Indisulam in non-small cell lung cancer by promoting alternative splicing of proto-oncogenes
by: Tongjia Zhang, et al.
Published: (2025-06-01) -
The Oncogenic Role of UBXN1 in Gastric Cancer Is Attributed to the METTL16‐Mediated m6A Methylation and Histone Modifications
by: Kesong Shi, et al.
Published: (2025-03-01) -
The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing
by: Colin E. Fowler, et al.
Published: (2025-07-01) -
PRMT1 alleviates isoprenaline-induced myocardial hypertrophy by methylating SRSF1
by: Yan Zi, et al.
Published: (2024-12-01)